1. Brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion
   Maria A. Gubbiotti et al, 2023, Clinical Neurology and Neurosurgery CrossRef
2. TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
   Sandeep Kumar Parvathareddy et al, 2022, Frontiers in Endocrinology CrossRef
3. Clinical and molecular features of progressive papillary thyroid microcarcinoma
   Zhiyuan Wang et al, 2024, International Journal of Surgery CrossRef
4. Novel molecular typing reveals the risk of recurrence in patients with early-stage papillary thyroid cancer
   Mingyu Sun et al, 2024, Thyroid Research CrossRef
5. Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population
   Zhiting Wang et al, 2024, Thyroid® CrossRef
6. Correlation research between preoperative ultrasonographic features and postoperative recurrence of papillary thyroid carcinoma: a retrospective study
   Qing Feng et al, 2023, Journal of Ultrasound CrossRef
7. Correlation between Ultrasonographic Appearance of Papillary Thyroid Microcarcinoma and BRAF V600E Mutation
   Songnian Liang et al, 2022, Journal of Oncology CrossRef
8. Risk Factors for Cervical Lymph Node Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
   Sandeep Kumar Parvathareddy et al, 2022, Journal of Clinical Medicine CrossRef